OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Cytokinetics Inc/  US23282W6057  /

NASDAQ
5/3/2024  10:00:00 PM Chg. +0.9300 Volume Bid1:59:59 AM Ask1:59:59 AM High Low
65.2700USD +1.45% 900,208
Turnover: 44.22 mill.		 63.6200Bid Size: 100 66.5000Ask Size: 100 66.6050 65.0000
GlobeNewswire 5/2 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 4/29 Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-...
GlobeNewswire 4/24 Cytokinetics to Announce First Quarter Results on May 8, 2024
GlobeNewswire 4/10 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at t...
GlobeNewswire 4/5 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...
GlobeNewswire 4/5 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...
GlobeNewswire 4/2 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 4/1 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 3/25 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual...
GlobeNewswire 3/4 Cytokinetics to Participate in March Investor Conferences
GlobeNewswire 3/1 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2/29 Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
GlobeNewswire 2/28 Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase E...
GlobeNewswire 2/27 Cytokinetics Reports Fourth Quarter 2023 Financial Results
GlobeNewswire 2/15 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 2/13 Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
GlobeNewswire 2/6 Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire 1/29 Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
GlobeNewswire 1/25 Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial...
GlobeNewswire 1/18 Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
GlobeNewswire 1/3 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 1/2 Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/27/2023 Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Afi...
GlobeNewswire 12/26/2023 Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, t...
GlobeNewswire 12/12/2023 Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...